Tag:
meningitis
Latest Headlines
Latest Headlines
Gates-backed vaccine slashes African meningitis deaths
In the first 5 months of 2013, 857 deaths were reported in countries under enhanced surveillance.
Novartis lands EU approval of meningitis B vaccine Bexsero
Novartis nabbed EU approval of Bexsero, a meningitis B vaccine the company has been banking on to bolster its lagging vaccine unit.
Novartis nabs EU approval for meningitis B vaccine Bexsero
Novartis has won European approval of Bexsero, its new meningitis B vaccine, which is central to the Big Pharma's drive to grow its big vaccine unit.
Novartis gains EU nod for vaccine hopeful Bexsero
Novartis ($NVS) nabbed European approval for its new meningitis B vaccine Bexsero, for use in patients 2 months of age and older.
Novartis rides high on Bexsero study results
Novartis, still riding high on a European Medicine Agency committee backing of its meningitis vaccine Bexsero, confirmed more upbeat results from a study showing the shot offered broad protection to infants.
Sanofi Pasteur nabs Menactra expansion in Canada
Health Canada gave the nod to Sanofi Pasteur Canada to expand the indication for Menactra to infants 9 months of age.
Novartis nabs EU committee backing for meningitis B vaccine
Novartis ($NVS) hit a key turning point with its vaccines division when a European Union committee backed the company's Bexsero meningitis shot.
Novartis grabs EU committee support for first meningitis B vaccine
Novartis has scored a key endorsement for one of the brightest stars from its vaccines division. The European Union's Committee for Medicinal Products for Human Use (CHMP) backed approval of Bexsero, the Swiss drug giant's ($NVS) meningitis B vaccine that could become the first such shot to hit the market if the European Commission follows the CHMP's advice.
Novartis vaccines get booster shot with EMA nod for Bexsero
Novartis' struggling vaccine unit got a shot in the arm today when the European Medicines Agency (EMA) recommended for approval, Bexsero, its potential blockbuster vaccine for meningitis B.
Meningitis vaccine ruled safe for warm storage
The World Health Organization deemed an inexpensive meningitis vaccine safe out of cold storage for four days, meaning health workers can more easily transport the drug to remote parts of Africa where meningitis A is common.
